Repositorio Dspace

Ustekinumab is effective and safe in the long-term treatment of erythrodermic psoriasis: Multicenter study in daily practice

Mostrar el registro sencillo del ítem

dc.contributor.author Plana, Clara
dc.contributor.author Concha-Garzon, María-J
dc.contributor.author Rocamora, Vicen-C
dc.contributor.author BaniAndrés, Ofelia
dc.contributor.author Feltes, Rosa
dc.contributor.author López-Estebaranz, José-L
dc.contributor.author Garcías-Ladaria, Joan
dc.contributor.author Carrascosa, José-Manuel
dc.contributor.author Vilarrasa, Eva
dc.contributor.author Soria, Caridad
dc.contributor.author Navajas, Belén
dc.contributor.author Llamas-Velasco, Mar
dc.contributor.author Dauden, Esteban
dc.date.accessioned 2025-11-18T09:33:56Z
dc.date.available 2025-11-18T09:33:56Z
dc.date.issued 2024-06
dc.identifier.citation Plana C, Concha-Garzón MJ, Rocamora VC, Baniandrés O, Feltes R, López-Estebaranz JL, et al. Ustekinumab is effective and safe in the long-term treatment of erythrodermic psoriasis: Multicenter study in daily practice. JEADV Clinical Practice. junio de 2024;3(2):604-10.
dc.identifier.issn 2768-6566
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/20890
dc.description.abstract OBJECTIVE: To describe overall survival (OS) and disease-free survival (DFS) in a cohort of tongue cancer patients, together with the corresponding demographic, tumor and surgical characteristics. METHODS: A retrospective study was made of 205 consecutive
dc.language.iso eng
dc.publisher Wiley
dc.title Ustekinumab is effective and safe in the long-term treatment of erythrodermic psoriasis: Multicenter study in daily practice
dc.type info:eu-repo/semantics/article
dc.relation.publisherversion https://onlinelibrary.wiley.com/doi/10.1002/jvc2.325
dc.identifier.doi 10.1002/jvc2.325
dc.journal.title Jeadv Clinical Practice


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta